Mayara I. De Paula
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti-thymocyte globulin without CMV prophylaxis - a cohort single-center study.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: August 21, 2020
The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis.
Journal: Transplantation
Published: January 25, 2020
Use of mTOR inhibitor as prophylaxis for cytomegalovirus disease after kidney transplantation: A natural experiment.
Journal: Clinical transplantation
Published: April 29, 2019
Clinical features and outcomes of kidney transplant recipients with focal segmental glomerulosclerosis recurrence.
Journal: Nephrology (Carlton, Vic.)
Published: March 12, 2019
Prospective randomized study comparing everolimus and mycophenolate sodium in de novo kidney transplant recipients from expanded criteria deceased donor.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: February 19, 2019
Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: August 23, 2018
Flavonoids from Plinia cauliflora (Mart.) Kausel (Myrtaceae) with antifungal activity.
Journal: Natural product research
Published: April 06, 2018
Cost-Effectiveness Analysis of Everolimus versus Mycophenolate in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis for Cytomegalovirus Infection: A Short-Term Pharmacoeconomic Evaluation (12 Months).
Journal: Value in health regional issues
Published: March 16, 2017
Pharmacokinetics and Long-Term Safety and Tolerability of Everolimus in Renal Transplant Recipients Converted From Cyclosporine.
Journal: Therapeutic drug monitoring
Published: August 15, 2015
Long-Term Follow-Up of De Novo Use of mTOR and Calcineurin Inhibitors After Kidney Transplantation.
Journal: Therapeutic drug monitoring
Published: June 30, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026